Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    "Hemangioblastoma"
Show Display Options
Rank Status Study
1 Terminated Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
Conditions: Hemangioblastomas;   Von Hippel Lindau Disease
Intervention: Drug: Avastin
2 Completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Conditions: Von Hippel-Lindau Disease;   CNS Hemangioblastoma;   Retinal Hemangioblastoma
Intervention: Drug: PTK787/ZK 222584
3 Active, not recruiting Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System
Condition: Hemangioblastoma (HB) of the Central Nervous System (CNS)
Intervention: Other: evaluation of anxiety with psychosocial scales
4 Active, not recruiting Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
Conditions: Hemangioblastoma;   Hippel Lindau Disease
5 Enrolling by invitation Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Vorinostat
6 Terminated
Has Results
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
Conditions: Von Hippel-Lindau Syndrome;   Renal Cell Carcinoma;   Hemangioblastoma
Intervention: Drug: SU011248
7 Completed
Has Results
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Conditions: CNS Cancer;   Meningioma;   Intracranial Hemangiopericytoma;   Hemangioblastoma;   Neurofibromatosis
Intervention: Drug: Sunitinib
8 Completed Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
Conditions: Von Hippel-Lindau Disease;   Hemangioblastoma;   Renal Cell Carcinoma;   Pheochromocytoma;   Pancreatic Neuroendocrine Tumor
Intervention: Other: 89Zr bevacizumab PET scan
9 Terminated
Has Results
TKI 258 in Von Hippel-Lindau Syndrome (VHL)
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Dovitinib
10 Enrolling by invitation Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
Condition: Von Hippel-Lindaus Disease
11 Completed Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
Conditions: Deafness;   Kidney Diseases;   Kidney Neoplasms;   Neoplasms;   Retinal Diseases

Study has passed its completion date and status has not been verified in more than two years.